Obesity and left ventricular dilatation in young adulthood: The Bogalusa Heart Study

Clinical Cardiology

Volumn 34, Issue 3, 2011, Pages 153-159

  Bazzano, Lydia A ^a   Belame, Suresh N ^b   Patel, Dharmendrakumar A ^c   Chen, Wei ^a,c   Srinivasan, Santhur ^a,c   McIlwain, Elizabeth ^c   Berenson, Gerald S ^a,c  

^a TULANE UNIVERSITY   (United States)

^b Office of Public Health   (United States)

^c Tulane Center for Cardiovascular Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AGE; ARTICLE; BODY MASS; BRAIN VENTRICLE DILATATION; CONFIDENCE INTERVAL; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; M MODE ECHOCARDIOGRAPHY; MAJOR CLINICAL STUDY; MALE; OBESITY; RACE; RISK FACTOR; STANDARD; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; COHORT STUDIES; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY; FEMALE; HEART VENTRICLES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; LOUISIANA; MALE; OBESITY; RISK FACTORS;

EID: 79952728030     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.20896     Document Type: Article

References (32)

1. Yusuf S, Reddy S, Ounpuu S, et al. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation. 2001;104:2746-2753. (Pubitemid 33108145)
2. Lloyd-Jones D, Adams RJ, Brown TM, et al.; on behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics - 2010 update: a report fromthe American Heart Association. Circulation. 2010;121:e46-e215.
3. Nestico PF, Hakki AH, Iskandrian AS. Left ventricular dilatation: prognostic value in sever left ventricular dysfunction secondary to coronary artery disease. Chest. 1985;88:215-220. (Pubitemid 15004988)
4. Galderisi M, Lauer MS, Levy D. Echocardiographic determinants of clinical outcome in subjects with coronary artery disease (the Framingham Heart Study). Am J Cardiol. 1992;70:971-976.
5. Gaudron P, Eilles C, Kugler I, et al. Progressive left ventricular dysfunction and remodeling after myocardial infarction. Potential mechanisms and early predictors. Circulation. 1993;87:755-763. (Pubitemid 23070806)
6. Lauer MS, Evans JC, Levy D. Prognostic implications of subclinical left ventricular dilatation and systolic dysfunction in men free of overt cardiovascular disease (the Framingham Heart Study). Am J Cardiol. 1992;70:1180-1184.
7. Vasan RS, Larson MG, Benjamin EJ, et al. Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction. N Engl J Med. 1997;336:1350-1355. (Pubitemid 27208618)
8. Berenson GS, McMahan CA, Voors AW, et al. Cardiovascular Risk Factors in Children - The Early Natural History of Atherosclerosis and Essential Hypertension. New York, NY: Oxford University Press; 1980.
9. Berenson GS, ed. Evolution of Cardiovascular Risk Factors in Early Life: Perspectives on Causation. Causation of Cardiovascular Risk Factors in Children. New York, NY: Raven Press; 1986:1-26.
10. Srinivasan SR, Berenson GS. Serum lipoproteins in children and methods for study. In: Lewis LA, ed. Handbook of Electrophoresis. Boca Raton, FL: CRC Press; 1983; 185-204.
11. Mathews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-419. (Pubitemid 15018832)
12. Haffner SM, Miettinen H, Stern MP. The homeostasis model in the San Antonio Heart Study. Diabetes Care. 1997;20:1087-1092. (Pubitemid 27274268)
13. Sahn DJ, DeMaria A, Kisslo J, et al. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978;58:1072-1083. (Pubitemid 9091990)
14. Devereux RB. Detection of left ventricular hypertrophy by M-mode echocardiography. Anatomic validation, standardization, and comparison to other methods. Hypertension. 1987;9:II19-II26.
15. Kuch B, Hense HW, Gneiting B, et al. Body composition and prevalence of left ventricular hypertrophy. Circulation. 2000;102:405-410. (Pubitemid 30490678)
16. Daniels SR, Kimball TR, Morrison JA, et al. Indexing left ventricular mass to account for differences in body size in children and adolescents without cardiovascular disease. Am J Cardiology. 1995;76:699-701.
17. Whalley GA, Gamble GD, Doughty RN, et al. Left ventricular mass correlates with fat - free mass but not fat mass in adults. J Hypertens. 1999;17:569-574. (Pubitemid 29308568)
18. Li X, Li S, Ulusoy E, et al. Childhood adiposity as a predictor of cardiac mass in adulthood: The Bogalusa Heart Study. Circulation. 2004;110:3488-3492. (Pubitemid 39602228)
19. Srinivasan SR, Myers L, Berenson GS. Predictability of childhood adiposity and insulin for developing insulin resistance syndrome (syndrome X) in young adulthood: The Bogalusa Heart Study. Diabetes. 2002;51:204-209. (Pubitemid 34517999)
20. Mokdad AH, Bowman BA, Ford ES, et al. The continuing epidemics of obesity and diabetes in the United States. JAMA. 2001;286:1195-1200. (Pubitemid 33015548)
21. Ogden CL, Carroll MD, Curtin LR, et al. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA. 2002;288:1728-1732.
22. Finkelstein EA, Fiebelkorn IC, Wang G. State-level estimates of annual medical expenditures attributable to obesity. Obes Res. 2004;12:18-24. (Pubitemid 41137483)
23. Allison DB, Fontaine KR, Manson JE, et al. Annual deaths attributable to obesity in the United States. JAMA. 1999;282:1530-1538. (Pubitemid 29504046)
24. McGavock JM, Victor RG, Unger RH, et al. Adiposity of the heart, revisited. Ann Intern Med. 2006;144:517-524. (Pubitemid 46780675)
25. Kenchaiah S, Evans JC, Levy D, et al. Obesity and the risk of heart failure. N Engl J Med. 2002;347:305-313. (Pubitemid 34815352)
26. Litwin SE. The growing problem of obesity and the heart. J Am Coll Cardiol. 2006;47:617-619.
27. Sacks HS, Fain JN. Human epicardial adipose tissue: a review. Am Heart J. 2007;153:907-917. (Pubitemid 46809849)
28. Su L, Siegel JE, Fishbein MC. Adipose tissue in myocardial infarction. Cardiovasc Pathol. 2004;13:98-102. (Pubitemid 38366428)
29. Abel ED, Litwin SE, Sweeney G. Cardiac remodeling in obesity. Physiol Rev. 2008;88:389-419. (Pubitemid 351520084)
30. Rider OJ, Francis JM, Ali MK, et al. Beneficial cardiovascular effects of bariatric surgical and dietary weight loss in obesity. J Am Coll Cardiol. 2009;54:718-726.
31. Zhou YT, Grayburn P, Karim A, et al. Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci. 2000;97:1784-1789. (Pubitemid 30118520)
32. MacMahon SW, Wilcken DE, Macdonald GJ. The effect of weight reduction on left ventricular mass. A randomized controlled trial in young, overweight hypertensive patients. N Engl J Med. 1986;314:334-339. (Pubitemid 16166260)